Canbay A - Search Results

1

Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC.

Sydor S, Best J, Messerschmidt I, Manka P, Vilchez-Vargas R, Brodesser S, Lucas C, Wegehaupt A, Wenning C, Aßmuth S, Hohenester S, Link A, Faber KN, Moshage H, Cubero FJ, Friedman SL, Gerken G, Trauner M, Canbay A, Bechmann LP. Sydor S, et al. Among authors: canbay a. Clin Transl Gastroenterol. 2020 Mar;11(3):e00131. doi: 10.14309/ctg.0000000000000131. Clin Transl Gastroenterol. 2020. PMID: 32352707 Free PMC article.

2

Apoptotic body engulfment by a human stellate cell line is profibrogenic.

Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ. Canbay A, et al. Lab Invest. 2003 May;83(5):655-63. doi: 10.1097/01.lab.0000069036.63405.5c. Lab Invest. 2003. PMID: 12746475 Free article.

3

Apoptosis: the nexus of liver injury and fibrosis.

Canbay A, Friedman S, Gores GJ. Canbay A, et al. Hepatology. 2004 Feb;39(2):273-8. doi: 10.1002/hep.20051. Hepatology. 2004. PMID: 14767974 Review. No abstract available.

4

Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis.

Baumann M, Witzke O, Canbay A, Patschan S, Treichel U, Gerken G, Philipp T, Kribben A. Baumann M, et al. Among authors: canbay a. Hepatogastroenterology. 2004 Sep-Oct;51(59):1451-3. Hepatogastroenterology. 2004. PMID: 15362774

5

The relationship between apoptosis and non-alcoholic fatty liver disease: an evolutionary cornerstone turned pathogenic.

Canbay A, Gieseler RK, Gores GJ, Gerken G. Canbay A, et al. Z Gastroenterol. 2005 Feb;43(2):211-7. doi: 10.1055/s-2004-813744. Z Gastroenterol. 2005. PMID: 15700216 Review.

6

Overweight patients are more susceptible for acute liver failure.

Canbay A, Chen SY, Gieseler RK, Malago M, Karliova M, Gerken G, Broelsch CE, Treichel U. Canbay A, et al. Hepatogastroenterology. 2005 Sep-Oct;52(65):1516-20. Hepatogastroenterology. 2005. PMID: 16201109

7

Apoptosis and fibrosis in non-alcoholic fatty liver disease.

Canbay A, Kip SN, Kahraman A, Gieseler RK, Nayci A, Gerken G. Canbay A, et al. Turk J Gastroenterol. 2005 Mar;16(1):1-6. Turk J Gastroenterol. 2005. PMID: 16252180 Free article. Review.

8

Non-alcoholic fatty liver disease in HIV-positive patients predisposes for acute-on-chronic liver failure: two cases.

Kahraman A, Miller M, Gieseler RK, Gerken G, Scolaro MJ, Canbay A. Kahraman A, et al. Among authors: canbay a. Eur J Gastroenterol Hepatol. 2006 Jan;18(1):101-5. doi: 10.1097/00042737-200601000-00018. Eur J Gastroenterol Hepatol. 2006. PMID: 16357628

9

Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure.

Canbay A, Bechmann LP, Best J, Jochum C, Treichel U, Gerken G. Canbay A, et al. Z Gastroenterol. 2006 Mar;44(3):245-8. doi: 10.1055/s-2006-926502. Z Gastroenterol. 2006. PMID: 16514570

10

[Specific therapy in acute liver failure].

Canbay A, Gerken G. Canbay A, et al. Med Klin (Munich). 2006 Mar 22;101 Suppl 1:111-4. Med Klin (Munich). 2006. PMID: 16802533 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters